ASCO 2015 Highlights

Ipilimumab Combined with Cytotoxic Chemotherapy in Metastatic Melanoma

ASCO 2014 – Immuno-Oncology, ASCO

Conference Correspondent

Doublets and Triple Combinations in Metastatic Melanoma

ASCO 2014 – Immuno-Oncology, ASCO

Conference Correspondent

Stereotactic Radiosurgery and Ipilimumab for Melanoma Brain Metastases

ASCO 2014 – Immuno-Oncology, ASCO

Conference Correspondent

Peginterferon alfa-2b Combined with Ipilimumab for Advanced Melanoma

ASCO 2014 – Immuno-Oncology, ASCO

Conference Correspondent

Single-Agent Nivolumab in Advanced NSCLC

ASCO 2014 – Immuno-Oncology, ASCO

Conference Correspondent

Nivolumab Combined with Platinum-Based Doublet Chemotherapy in Advanced NSCLC

ASCO 2014 – Immuno-Oncology, ASCO

Conference Correspondent

Next-Generation TKIs

ASCO 2014 – Lung Cancer, ASCO

Conference Correspondent

Value-Based Use of Molecular and Genomic Markers

ASCO 2014 – Lung Cancer, ASCO

Conference Correspondent

New Results with Existing Agents

ASCO 2014 – Lung Cancer, ASCO

Conference Correspondent

New Molecular Targets for NSCLC

ASCO 2014 – Lung Cancer, ASCO

Conference Correspondent

Page 230 of 330